Article info

Extended report
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

Authors

  1. Correspondence to Professor Charles Peterfy, Spire Sciences, Inc., 5314 Boca Marina Circle North, Boca Raton, FL 33487, USA; charles.peterfy{at}spiresciences.com
View Full Text

Citation

Peterfy C, Emery P, Tak PP, et al
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

Publication history

  • Received May 30, 2014
  • Revised September 24, 2014
  • Accepted October 5, 2014
  • First published October 29, 2014.
Online issue publication 
December 11, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.